Minor criteria include elevated erythrocyte adenosine deaminase (eADA) level activity, congenital anomalies associated with DBA, elevated fetal hemoglobin, and no evidence of another inherited bone marrow failure syndrome. The gene discussed is ADA; the disease is Diamond-Blackfan anemia.